David D. Meek Mirati Therapeutics, Inc. (MRTX) insider trading activity

MRTX Quotes by TradingView

David D. Meek is Chief Executive Officer of Mirati Therapeutics, Inc.. Currently has a direct ownership of 151,171 shares of MRTX, which is worth approximately $0. The most recent transaction as insider was on Jan 20, 2023, when has been sold 89,379 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 151K
0% 3M change
0% 12M change
Total Value Held $0

David D. Meek Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 20 2023
BUY
Grant, award, or other acquisition
-
89,379 Added 37.16%
151,171 Common Stock
Jan 17 2023
SELL
Open market or private sale
$134,726 $42.38 p/Share
3,179 Reduced 4.89%
61,792 Common Stock
Dec 21 2022
SELL
Open market or private sale
$186,532 $40.41 p/Share
4,616 Reduced 6.63%
64,971 Common Stock
Dec 19 2022
BUY
Grant, award, or other acquisition
-
35,425 Added 33.73%
69,587 Common Stock
Jan 14 2022
BUY
Grant, award, or other acquisition
-
34,057 Added 50.0%
34,057 Common Stock

Also insider at

ETTX
Entasis Therapeutics Holdings Inc. Healthcare
Director
QURE
uniQure N.V. Healthcare
Director
FUSN
Fusion Pharmaceuticals Inc. Healthcare
CGEM
Cullinan Oncology, Inc. Healthcare
DDM

David D. Meek

Chief Executive Officer
Waltham, MA

Track Institutional and Insider Activities on MRTX

Follow Mirati Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRTX shares.

Notify only if

Insider Trading

Get notified when an Mirati Therapeutics, Inc. insider buys or sells MRTX shares.

Notify only if

News

Receive news related to Mirati Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRTX